John Lewicki
Chief Tech/Sci/R&D Officer bij MEREO BIOPHARMA GROUP PLC
Vermogen: 2 402 $ op 31-03-2024
Profiel
John A.
Lewicki is currently the Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Prior to this, he worked at OncoMed Pharmaceuticals, Inc. as the President, Chief Executive Officer & Director from 2018 to 2019.
He also worked at Scios, Inc. as a Principal from 1983 to 2000.
Dr. Lewicki holds a doctorate degree from the University of California San Diego.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
25-01-2024 | 3 640 ( 0.00% ) | 2 402 $ | 31-03-2024 |
Actieve functies van John Lewicki
Bedrijven | Functie | Begin |
---|---|---|
MEREO BIOPHARMA GROUP PLC | Chief Tech/Sci/R&D Officer | 01-07-2020 |
Eerdere bekende functies van John Lewicki
Bedrijven | Functie | Einde |
---|---|---|
ONCOMED PHARMACEUTICALS INC | Chief Executive Officer | 23-04-2019 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van John Lewicki
University of California San Diego | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MEREO BIOPHARMA GROUP PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |